Complete remission from intralesional talimogene laherparepvec for regionally advanced Merkel cell carcinoma in an immunocompromised solid organ transplant patient.

Hirotsu, Kelsey E; Hua, Vivian; Tran, Anhthy T; Morris, Laura; Reddy, Sunil A; Kwong, Bernice Y; Zaba, Lisa C

Hirotsu, Kelsey E; Hua, Vivian; Tran, Anhthy T; Morris, Laura; Reddy, Sunil A; Kwong, Bernice Y; Zaba, Lisa C.

Afiliação

Hirotsu KE; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
Hua V; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
Tran AT; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
Morris L; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Reddy SA; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Kwong BY; Department of Dermatology, Stanford University School of Medicine, Stanford, California.
Zaba LC; Department of Dermatology, Stanford University School of Medicine, Stanford, California.

JAAD Case Rep ; 13: 144-146, 2021 Jul.

Article em En | MEDLINE | ID: mdl-34195326

Palavras-chave

ICI, immune checkpoint inhibitor; MCC, Merkel cell carcinoma; Merkel cell carcinoma; T-VEC, talimogene laherparepvec; cutaneous oncology; herpes; immunosuppressed; oncodermatology; talimogene laherparepvec; transplant

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: JAAD Case Rep Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google